Accessibility Menu

Edwards Lifesciences(FRA) EWL

Market Cap€44.77BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€78.08
+0.52%
+0.40Today

Edwards Lifesciences Financials at a Glance

Market Cap

€44.77BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€5.58K

Net Income (TTM)

€838.30

EPS (TTM)

€1.44

P/E Ratio

53.81

Dividend

€0.00

Beta (Volatility)

0.13 (Low)

Price

€78.08

Volume

0

Open

€77.56

Previous Close

€78.08

Daily Range

€77.24 - €78.32

52-Week Range

€59.49 - €83.52

Estimated Earnings Date

N/A

EWL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Edwards Lifesciences

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

16,000

CEO

Bernard J. Zovighian, MBA

Website

www.edwards.com

EWL Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

9.19%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

1.86%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€44.77BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

576.40M

Volume

0

Avg. Volume

84.258

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Edwards Lifesciences Performance Analysis

Edwards Lifesciences annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 5,121,343,03815.7%
20232023-12-31EUR 4,634,102,020-9.5%
20242024-12-31EUR 5,028,701,5668.5%
20252025-12-31EUR 5,376,323,3616.9%
Edwards Lifesciences annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 2.3215.1%
20232023-12-31EUR 2.13-8.2%
20242024-12-31EUR 1.35-36.6%
20252025-12-31EUR 1.6018.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€1.50K

+1.1%

Gross Profit

€1.17K

+1.1%

Gross Margin

78.09%

+1.0%

Market Cap

€44.77BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€2.86

N/A

Employees

16,000

N/A

Net Income

€207.62

+0.7%

EBITDA

€492.90

+1.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€3.16K

-6.7%

Total Debt

€616.11

+1.0%

Accounts Receivable

€673.84

+1.1%

Inventory

€989.42

+1.0%

Long Term Debt

€595.03

+1.0%

Short Term Debt

€21.08

+1.0%

Return on Assets

7.11%

+0.6%

Return on Invested Capital

17.16%

+0.9%

Free Cash Flow

€503.02

+2.5%

Operating Cash Flow

€560.91

+2.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About EWL

What is the current price of Edwards Lifesciences?

Edwards Lifesciences is trading at €78.08 per share.

What is the 52-week range for Edwards Lifesciences?

Over the past 52 weeks, Edwards Lifesciences has traded between €59.49 and €83.52.

How much debt does Edwards Lifesciences have?

As of the most recent reporting period, Edwards Lifesciences reported total debt of €616.11M.

How much cash does Edwards Lifesciences have on hand?

Edwards Lifesciences reported €2.54B in cash and cash equivalents in its most recent financial results.

What is Edwards Lifesciences’s dividend yield?

Edwards Lifesciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services